Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1876 1
1945 5
1946 2
1947 2
1948 6
1950 5
1951 9
1952 10
1953 12
1954 10
1955 2
1956 10
1957 14
1958 7
1959 6
1960 10
1961 6
1962 10
1963 11
1964 16
1965 14
1966 13
1967 25
1968 16
1969 23
1970 13
1971 7
1972 14
1973 11
1974 16
1975 12
1976 15
1977 18
1978 8
1979 15
1980 14
1981 13
1982 14
1983 15
1984 13
1985 12
1986 7
1987 21
1988 24
1989 15
1990 20
1991 24
1992 15
1993 21
1994 11
1995 21
1996 19
1997 15
1998 11
1999 30
2000 24
2001 23
2002 30
2003 17
2004 30
2005 32
2006 31
2007 21
2008 25
2009 34
2010 27
2011 31
2012 48
2013 54
2014 42
2015 53
2016 67
2017 63
2018 55
2019 52
2020 65
2021 72
2022 53
2023 59
2024 43
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,628 results

Results by year

Filters applied: . Clear all
Page 1
Valette's Surgical Clinique.
[No authors listed] [No authors listed] Br Foreign Med Chir Rev. 1876 Jan;57(113):122-126. Br Foreign Med Chir Rev. 1876. PMID: 30162660 Free PMC article. Review. No abstract available.
[Guillaume Valette (1902-1982)].
Cohen DY. Cohen DY. Ann Pharm Fr. 1982;40(6):493-7. Ann Pharm Fr. 1982. PMID: 6764342 French. No abstract available.
The efficacy and tolerability of Valette: a postmarketing surveillance study.
Zimmermann T, Dietrich H, Wisser KH, Hoffmann H. Zimmermann T, et al. Eur J Contracept Reprod Health Care. 1999 Sep;4(3):155-64. Eur J Contracept Reprod Health Care. 1999. PMID: 10574641
OBJECTIVES AND METHODS: A postmarketing survey was carried out to determine the efficacy and tolerability of Valette (dienogest 2.0 mg and ethinylestradiol 0.03 mg) in routine gynecological practice. ...CONCLUSIONS: These results confirm those from previous clinical trials …
OBJECTIVES AND METHODS: A postmarketing survey was carried out to determine the efficacy and tolerability of Valette (dienogest 2.0 m …
A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system.
Klinger G, Gräser T, Mellinger U, Moore C, Vogelsang H, Groh A, Latterman C, Klinger G. Klinger G, et al. Gynecol Endocrinol. 2000 Feb;14(1):15-24. doi: 10.3109/09513590009167655. Gynecol Endocrinol. 2000. PMID: 10813102 Free article. Clinical Trial.
Valette decreased CD4 lymphocytes after 10 days' treatment; Lovelle had the opposite effect. ...Levels of non-immunoglobulin serum components fluctuated; macroglobulin was increased with Valette. However, total protein and albumin levels were reduced more with Lovel …
Valette decreased CD4 lymphocytes after 10 days' treatment; Lovelle had the opposite effect. ...Levels of non-immunoglobulin serum co …
"Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients." Myriam Delaunay, Jacques Cadranel, Amelie Lusque, Nicolas Meyer, Valerie Gounant, Denis Moro-Sibilot, Jean-Marie Michot, Judith Raimbourg, Nicolas Girard, Florian Guisier, David Planchard, Anne-Cecile Metivier, Pascale Tomasini, Eric Dansin, Maurice Perol, Marion Campana, Oliver Gautschi, Martin Fruh, Jean-David Fumet, Clarisse Audigier-Valette, Sebastien Couraud, Stephane Dalle, Marie-Therese Leccia, Marion Jaffro, Samia Collot, Gregoire Prevot, Julie Milia and Julien Mazieres. Eur Respir J 2017; 50: 1700050.
[No authors listed] [No authors listed] Eur Respir J. 2017 Nov 9;50(5):1750050. doi: 10.1183/13993003.50050-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29122923 Free article. No abstract available.
The effects of Valette on skin and hair: a post-marketing surveillance study.
Zimmermann T, Wisser KH, Dietrich H. Zimmermann T, et al. Int J Clin Pract. 2000 Mar;54(2):85-91. Int J Clin Pract. 2000. PMID: 10824362
The effects of Valette--an oral contraceptive containing ethinyloestradiol 0.03 mg and the antiandrogenic progestogen dienogest 2.0 mg--on the skin and hair were surveyed over 63,474 cycles in 10,718 women in routine gynaecological practice. ...Self-assessments indicated l …
The effects of Valette--an oral contraceptive containing ethinyloestradiol 0.03 mg and the antiandrogenic progestogen dienogest 2.0 m …
The authors reply.
Valette X, du Cheyron D. Valette X, et al. Crit Care Med. 2017 Jul;45(7):e746-e747. doi: 10.1097/CCM.0000000000002456. Crit Care Med. 2017. PMID: 28622246 No abstract available.
Anakinra for patients with COVID-19.
Valette X, Cheyron DD. Valette X, et al. Lancet Rheumatol. 2020 Jul;2(7):e382. doi: 10.1016/S2665-9913(20)30176-4. Epub 2020 Jun 25. Lancet Rheumatol. 2020. PMID: 32835234 Free PMC article. No abstract available.
1,628 results